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Abstract 
Pancreatic plasmacytoma is a rare disorder which may present with obstructive jaundice. 
Only eighteen cases have been reported in the English language literature. We present 
the first case of pancreatic plasmacytoma and gastric plasmacytoma diagnosed with 
endoscopic ultrasound-guided fine needle aspiration (EUS-FNA). A 75-year-old male 
with a known history of multiple myeloma presented with obstructive jaundice and a 
pancreatic mass. A concomitant gastric mass due to gastric plasmacytoma was seen. The 
diagnosis was established via EUS-FNA of the pancreatic mass. Pancreatic plasmacytoma 
should be suspected in patients with a history of myeloma. EUS-FNA is a safe and 
effective modality in the diagnosis of pancreatic plasmacytoma. Radiation therapy 
should be the first-line of therapy in treating pancreatic plasmacytomas. 
Introduction 
Extramedullary plasmacytomas consist of neoplastic plasma cell proliferation that 
occurs outside the bone marrow. Extraskeletal plasmacytomas are infrequent, occurring 
in fewer than 5% of plasma cell neoplasms [1]. Pancreatic plasmacytomas are rare, with 
only eighteen cases identified in the English language literature. Endoscopic ultrasound  
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provides detailed imaging of the pancreas and accurate fine needle aspiration tissue 
sampling [2]. We describe a case of concomitant pancreatic and gastric plasmacytoma 
diagnosed with endoscopic ultrasound-guided fine needle aspiration (EUS-FNA) of the 
pancreas and endoscopic biopsy of the stomach in a patient with multiple myeloma.  
Case Report 
A 75-year-old male with a 10-year history of multiple myeloma treated with chemotherapy and 
radiation therapy presented with three weeks of progressive fatigue and jaundice. His past medical 
history included coronary artery disease, peripheral neuropathy and deep venous thrombosis. Physical 
exam revealed icteric sclerae and a normal abdominal examination. Laboratory studies revealed anemia 
with a hemoglobin of 8.2 g/dl and an obstructive liver enzyme pattern with a total bilirubin of 6.9 mg/dl, 
alkaline phosphatase of 347 U/l and ALT of 528 U/l. Abdominal ultrasound identified a 5.3 cm focal 
lesion arising from the head/proximal body of the pancreas, with a lobular contour and inhomogenous 
texture. The common bile duct was dilated to 2 cm. Fascial and maxillary computed tomography scan 
was unremarkable.  
Upper endoscopy (esophagogastroduodenoscopy) identified a 4 cm gastric mass with a large 
adherent blood clot, located in the proximal body along the greater curvature, with overlying ulceration 
(fig. 1). Forceps biopsies were obtained from the edge of the gastric mass. Pathology revealed reactive 
gastric glands surrounded by a dense, diffuse infiltrate of plasmacytoid cells (fig. 2). These cells were 
characterized by a moderate amount of amphophilic cytoplasm and eccentric nuclei with scattered 
nuclear pleomorphism. Although many cells displayed a mature plasma cell phenotype, others appeared 
immature. The differential diagnosis included lymphocytic gastritis related to Helicobacter pylori, 
plasma cell-rich mucosa-associated lymphoid tissue (MALT)-type lymphoma, and plasmacytoma. 
Immunostain for Helicobacter species was negative, Mum1 (a myeloma-associated oncogene), kappa 
light chain and CD138 immunostains were positive, while lambda light chain stains were negative, 
consistent with involvement by the patient’s multiple myeloma. 
Linear endoscopic ultrasound examination (GFUCT-140, Olympus America, Center Valley, Pa., 
USA) identified a 4 × 5 cm hypoechoic, heterogenous mass in the head of the pancreas obstructing the 
bile duct (fig. 3). The bile duct measured 2 cm with some sludge within the duct. The pancreatic duct 
was not obstructed by the mass (measuring 1.8 mm in the body) and the pancreatic parenchyma in the 
body and tail was normal. No enlarged peripancreatic or celiac lymph nodes were seen. The 5 × 4 cm 
gastric mass had a similar sonographic appearance and was seen to abut the spleen. EUS-FNA of the 
pancreatic and gastric mass was performed. Both sites revealed a predominant monomorphic 
population of plasma cells, which were dispersed as single cells. The cells had round to oval eccentric 
nuclei, nuclear membrane irregularity, occasional prominent nucleoli and a fine to coarsely clumped 
chromatin pattern. The cytoplasm was abundant and basophilic, with a perinuclear clear zone. These 
cytologic features were consistent with plasmacytoma (fig. 4). 
The aspirated material obtained from the head of the pancreas was also sent for flow cytometry. 
Flow cytometry showed more than 60% of the cells to be positive for CD45 dim, CD38, and were 
cyto-kappa-restricted, confirming the diagnosis of plasmacytoma. The patient was treated with 
radiation therapy, which resulted in improvement of liver function tests. Six months later his liver 
enzymes remained normal and repeat imaging studies of the pancreas showed resolution of the 
pancreatic plasmacytoma. 
Discussion 
Plasmacytoma is an immunoproliferative monoclonal disorder of plasma cells that 
usually affects the bone marrow. Extramedullary plasmacytomas involve soft tissue 
organs outside the bone marrow and represent 3–4% of all plasma cell neoplasms. 
Plasmacytomas may be primary (in the absence of multiple myeloma of the bone 
marrow) or secondary (in the presence of multiple myeloma of the bone marrow) [3].  
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Plasmacytomas are composed of plasma cells of variable maturity, which are 
histologically analogous to those seen in multiple myeloma. The median age of 
presentation of extramedullary plasmacytomas is 55 years (10 years younger than 
patients with multiple myeloma) and the majority (three-fourths) are male [4]. The 
upper respiratory tract (oronasopharynx and paranasal sinuses) is the most common site 
(80%) of extramedullary plasmacytomas [5]. Approximately 10% of extramedullary 
plasmacytomas occur in the gastrointestinal tract, the stomach being the most frequent 
site [6]. 
The diagnosis of an extramedullary plasmacytoma depends on the demonstration of a 
monoclonal plasma cell tumor outside the bone marrow. Poorly differentiated pancreatic 
neoplasms and lymphoma may be difficult to differentiate from plasmacytomas; 
immunohistochemistry and flow cytometry play key roles in diagnosis. In our case, 
immunohistochemistry was performed on an endoscopic mucosal biopsy of the stomach 
and flow cytometry on EUS-FNA of the pancreas. In rare cases, extramedullary 
plasmacytoma may represent a marginal zone B-cell lymphoma that has undergone an 
extensive degree of plasmacytic differentiation, which signifies a worse prognosis [7]. 
Extramedullary gastric plasmacytomas may further cause a diagnostic dilemma in the 
differentiation from MALT-type lymphoma. The absence of morphologic criteria of 
gastric MALT including centrocyte-like cells, lymphoepithelial lesions, reactive follicles 
and absence of B-lymphocyte antigens (CD45 and CD20) helps in the differentiation [8]. 
It is very difficult to radiologically differentiate extramedullary plasmacytoma of the 
pancreas from other pancreatic tumors, especially those which show enhancement with 
intravenous contrast such as endocrine cell tumors and acinar cell neoplasms [9]. 
Sonographically, pancreatic plasmacytomas appear as hypoechoic, homogenous masses, 
well demarcated from the surrounding normal pancreatic parenchyma. This is the first 
case report of EUS-FNA confirming the diagnosis of a pancreas plasmacytoma. Diagnosis 
has been obtained in prior reports via percutaneous biopsy or laparotomy [3, 10]. As 
demonstrated in this case, EUS-FNA may also provide adequate material for flow 
cytometry analysis [11].  
The management of patients with extramedullary plasmacytoma may include 
radiation therapy, surgery, or combination therapy (surgery and/or chemotherapy or 
radiation) [12, 13]. Plasma cell tumors are highly sensitive to radiation therapy. Solitary 
plasmacytoma of the tail of the pancreas can also be managed by distal pancreatectomy 
in good surgical candidates [14]. Patients with extramedullary plasmactyoma who had 
combined surgery and radiation therapy had a median survival 25 years greater than 
those who had only surgical intervention (13 years) or only radiation therapy (12 years) 
[12].  
Conclusion 
In summary, we report a rare case of concomitant extramedullary gastric and 
pancreatic plasmacytoma which is the first report of pancreatic plasmacytoma diagnosed 
with EUS-FNA. Extramedullary plasmacytoma should be considered in the differential 
diagnosis in patients with multiple myeloma presenting with a pancreatic mass and/or 
obstructive jaundice.  
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Fig. 1. Endoscopic image of the ulcerated, raised gastric mass with adherent blood clot.  
 
 
 
Fig. 2. Gastric biopsy (H&E, high power magnification) with a diffuse infiltrate of plasmacytoid cells. 
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Fig. 3. Endoscopic ultrasound image of a hypoechoic mass in the head of the pancreas with FNA 
needle within the mass (arrow).  
 
 
 
Fig. 4. EUS-FNA cytology of the pancreatic mass (PAP stain) showing a predominant monomorphic 
population of plasma cells. 
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